|
Saddle River, NJ—(BUSINESS WIRE)—March 12, 2007— PDI, Inc. (NASDAQ: PDII), a diversified sales and marketing services provider to the biopharmaceutical industry, today announced that Susanne P. Reilly, Ph.D., vice president of talent management, will be a panelist on Competency Models: What the "Bleep" Are We Assessing??, a roundtable discussion exploring recent trends in Talent Assessment. The event will be held on March 14, 2007 at The University Club in New York City and is sponsored by WJM Associates, Inc.
For this discussion exploring thought leadership around talent assessment, Reilly and other panelists will discuss how executive competence is identified and nurtured, how talent assessment supports hiring selection, development and succession planning, and how it is linked to business goals. The panel will also explore how companies build reputations for talent development, and emerging trends in talent assessment.
At PDI, Inc., Reilly's responsibilities as vice president encompass all aspects of talent management, most notably talent acquisition and development. Reilly's team is accountable for providing top pharmaceutical sales talent to enable PDI's clients to meet their strategic goals. By utilizing best practice research and methodology, the team has been recognized as an industry leader in recruiting and hiring outstanding professionals. Prior to joining PDI in June 2005, Reilly was a senior consultant with Applied Research Corporation, a human resources consulting firm. Her experience in the pharmaceutical industry includes work for Johnson & Johnson and Pfizer. Reilly holds a Ph.D. in Applied Psychology from Stevens Institute of Technology, where she was a Robert Crooks Stanley Fellow. Reilly's research has appeared in peer review journals, as well as several professional publications.
Headquartered in New York City, WJM Associates is a recognized leader in the fields of executive and organizational development. WJM has a Faculty of over 100 experienced executive coaches and consultants delivering executive coaching, assessment and other organizational effectiveness services throughout the world.
For more information regarding this event, please contact Chrystal Sanchez of WJM at 212-972-7400 or csanchez@wjmassoc.com.
About PDI
PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry offering a comprehensive set of outsourced solutions for established and emerging pharmaceutical companies. PDI is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing, and commercialization expertise; and a philosophy of performance. Headquartered in Saddle River, NJ, PDI's sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients, and Select Access™, our targeted sales solution that leverages an existing infrastructure. PDI also offers marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM (R)) in Dresher, PA. The company's experience extends across multiple therapeutic categories and includes office and hospital-based initiatives. PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to maintaining the industry's highest quality employees.
For more information, visit the Company's website at www.pdi-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, changes in our operating expenses, adverse patent rulings, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of any stock repurchase programs, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2004, and PDI's periodic reports on Form 8-K filed with the Securities and Exchange Commission since January 1, 2005. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
CONTACT: PDI, Inc.
Scott A. Stoogenke, Executive Director, Marketing
201-574-8672
sstoogenke@pdi-inc.com
SOURCE: PDI, Inc.
|
